AHR and myeloid sarcoma: For example, elegant work (43) has shown that VD3DC from MS patients exhibited more pro-inflammatory features than VD3DC from healthy donors, due to alterations in the aryl hydrocarbon receptor (AhR) and NF-κB pathways, impairing their tolerogenic function.